NOVEN.COM: Keyword Density Checker

Total words: 1546 | 2-word phrases: 402 | 3-word phrases: 439 | 4-word phrases: 456

PAGE INFO

Title	Try to keep the title under 60 characters (12 characters) Home - Noven
Description	Try to keep the meta description between 50 - 160 characters (0 characters)
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	No H1 tag on the page (0 characters)

ONE WORD PHRASES 249 Words

#	Keyword	Frequency	Density
1	noven	14	5.62%
2	to	12	4.82%
3	of	12	4.82%
4	and	11	4.42%
5	our	11	4.42%
6	the	10	4.02%
7	health	9	3.61%
8	transdermal	9	3.61%
9	about	7	2.81%
10	areas	7	2.81%

TWO WORD PHRASES 402 Words

#	Keyword	Frequency	Density
1	informationboxed warning	5	1.24%
2	learn more	5	1.24%
3	transdermal system	5	1.24%
4	slideshow link	4	1.00%
5	full prescribing	4	1.00%
6	at noven	4	1.00%
7	system full	3	0.75%
8	estradiol ts	3	0.75%
9	product development	3	0.75%
10	combipatch® product	3	0.75%
11	health xelstrym®	3	0.75%
12	womens health	3	0.75%
13	daytrana® womens	3	0.75%
14	secuado® daytrana®	3	0.75%
15	philosophystrategy areas	3	0.75%
16	mental health	3	0.75%
17	development partnering	3	0.75%
18	diversity careers	3	0.75%
19	areas of	3	0.75%
20	of interest	3	0.75%

THREE WORD PHRASES 439 Words

#	Keyword	Frequency	Density
1	governance products therapeutic	3	0.68%
2	supplier diversity careers	3	0.68%
3	combipatch® product development	3	0.68%
4	product development partnering	3	0.68%
5	prescribing informationboxed warning	3	0.68%
6	daytrana® womens health	3	0.68%
7	of interest supplier	3	0.68%
8	interest supplier diversity	3	0.68%
9	transdermal system full	3	0.68%
10	secuado® daytrana® womens	3	0.68%
11	benefits join our	3	0.68%
12	join our team	3	0.68%
13	company governance products	3	0.68%
14	overview our mission	3	0.68%
15	health estradiol ts	2	0.46%
16	xelstrym® secuado® daytrana®	2	0.46%
17	health xelstrym® secuado®	2	0.46%
18	mental health xelstrym®	2	0.46%
19	womens health estradiol	2	0.46%
20	minivelle® combipatch® product	2	0.46%
21	estradiol ts minivelle®	2	0.46%
22	network noven cantm	2	0.46%
23	19992024 noven pharmaceuticals	2	0.46%
24	areas mental health	2	0.46%
25	areas of interest	2	0.46%
26	diversity careers life	2	0.46%
27	products and technologies	2	0.46%
28	at noven benefits	2	0.46%
29	noven benefits join	2	0.46%
30	our team responsibility	2	0.46%

FOUR WORD PHRASES 456 Words

#	Keyword	Frequency	Density
1	company governance products therapeutic	3	0.66%
2	benefits join our team	3	0.66%
3	secuado® daytrana® womens health	3	0.66%
4	combipatch® product development partnering	3	0.66%
5	interest supplier diversity careers	3	0.66%
6	of interest supplier diversity	3	0.66%
7	19992024 noven pharmaceuticals inc	2	0.44%
8	minivelle® combipatch® product development	2	0.44%
9	governance products therapeutic areas	2	0.44%
10	products therapeutic areas mental	2	0.44%
11	areas mental health xelstrym®	2	0.44%
12	health xelstrym® secuado® daytrana®	2	0.44%
13	you are about to	2	0.44%
14	daytrana® womens health estradiol	2	0.44%
15	womens health estradiol ts	2	0.44%
16	about overview our mission	2	0.44%
17	join our team responsibility	2	0.44%
18	philosophystrategy areas of interest	2	0.44%
19	areas of interest supplier	2	0.44%
20	parent company governance products	2	0.44%
21	access network noven cantm	2	0.44%
22	supplier diversity careers life	2	0.44%
23	at noven benefits join	2	0.44%
24	noven care access network	2	0.44%
25	care access network noven	2	0.44%
26	noven benefits join our	2	0.44%
27	xelstrym® secuado® daytrana® womens	2	0.44%
28	story parent company governance	2	0.44%
29	full prescribing informationboxed warning	2	0.44%
30	leadership our story parent	2	0.44%
31	our mission leadership our	2	0.44%
32	overview our mission leadership	2	0.44%
33	transdermal system cii full	2	0.44%
34	system cii full prescribing	2	0.44%
35	transdermal system full prescribing	2	0.44%
36	learn more advancing careers	1	0.22%
37	alliances learn more advancing	1	0.22%
38	more noven care access	1	0.22%
39	noven’s newly created patient	1	0.22%
40	newly created patient support	1	0.22%

EXTERNAL LINKS

#	URL	Whois	Check
1	https://www.psychiatrist.com/JCP/article/Pages/2019/v80/18nr12554.aspx	Whois	psychiatrist.com
2	https://www.secuado.com/NovenCAN	Whois	secuado.com
3	https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0862f02a-72a8-41cc-8845-57cf4974bb6f	Whois	nih.gov
4	https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=685eaf44-5944-4f38-afba-0a4fc0b3462b	Whois	nih.gov
5	https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2c312c31-3198-4775-91ab-294e0b4b9e7f	Whois	nih.gov
6	https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6c5c47ab-28ee-11e1-bfc2-0800200c9a66	Whois	nih.gov
7	https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=83198ef1-11c4-11e4-9191-0800200c9a66	Whois	nih.gov